byiShook Opinion
Apr 21, 2025 - 11:40
Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets. The post Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift appeared first on Investor's Business Daily.
Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.
The post Immunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic Shift appeared first on Investor's Business Daily.